Steven Sciuto

iOnctura has appointed Steven Sciuto as Chief Financial Officer

iOnctura has announced the appointment Steven Sciuto as its new Chief Financial Officer.

Sciuto holds over 15 years of corporate finance leadership and capital markets experience within the life sciences industry.

He most recently served as Vice President of Finance at Neurogene, after holding roles of increasing responsibility within the finance organisation.

Prior to this, Sciuto was Senior Director, Financial Planning and Analysis at Acorda Therapeutics, and held positions at Citi and Hovde Group.

Sciuto said he is “[looking] forward to working with the… team at iOnctura to drive financial and strategic initiatives, to accelerate development and ensure sustainable success over the coming years”.

Catherine Pickering, iOnctura’s Chief Executive Officer and Co-Founder of added: “Following our successful initiation of a number of phase 2 studies for our lead asset, roginolisib, we are committed to building a… leadership team that not only delivers on the promise of this asset but also strengthens our entire portfolio.”